Repligen CORP Form 4 insider transactions
NASDAQ
RGEN
Repligen CORPRepligen Corporation's CEO, Anthony Hunt, disposed of 2,000 shares of common stock as a gift to a donor advised fund on March 18, 2024.
NASDAQ
RGEN
Repligen CORPForm 4: Repligen Corp Director Margaret Pax Reports Acquisition of Stock Options and Restricted Stock Units
Director Margaret Pax reports acquisition of stock options and restricted stock units in Repligen Corp.
NASDAQ
RGEN
Repligen CORPSenior VP of R&D at Repligen Corp, Ralf Kuriyel, reports the exercise of stock options and subsequent sale of shares.
NASDAQ
RGEN
Repligen CORPRepligen's CEO, Anthony Hunt, exercised a stock option and sold shares of common stock on March 8, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPRepligen's CEO, Anthony Hunt, disposed of 2,867 shares of common stock on March 7, 2024, to cover tax withholding obligations related to the release of restricted stock units.
NASDAQ
RGEN
Repligen CORPRalf Kuriyel, Senior VP of R&D at Repligen Corp, disposed of 386 shares to cover tax withholding obligations.
NASDAQ
RGEN
Repligen CORPJames Bylund, Chief Operating Officer of Repligen Corp, disposed of 1,206 shares to cover tax obligations related to released restricted stock units on March 7, 2024.
NASDAQ
RGEN
Repligen CORPChristine Gebski, SVP at Repligen Corp, reports the disposal of 386 shares of common stock to cover tax obligations arising from the release of restricted stock units.
NASDAQ
RGEN
Repligen CORPRepligen's CEO, Anthony Hunt, disposed of shares to cover tax withholding obligations related to the release of performance and restricted stock units.
NASDAQ
RGEN
Repligen CORPChristine Gebski, a Repligen Corp executive, reports the disposal of 131 shares to cover tax obligations arising from the release of performance stock units.
NASDAQ
RGEN
Repligen CORPChief Operating Officer James Bylund of Repligen Corp reports disposals of common stock to cover tax obligations arising from the release of performance stock units.
NASDAQ
RGEN
Repligen CORPRalf Kuriyel, Senior VP of R&D at Repligen Corp, reports the withholding of 135 common stock shares to cover tax obligations related to the release of performance stock units on March 4, 2024.
NASDAQ
RGEN
Repligen CORPJames Bylund, Chief Operating Officer of Repligen Corp, acquired 50 shares of common stock on March 1, 2024, through a Performance Stock Unit award.
NASDAQ
RGEN
Repligen CORPRalf Kuriyel, Senior VP of R&D at Repligen Corp, reports acquisition of shares through a Performance Stock Unit award and disposition of shares to cover tax obligations.
NASDAQ
RGEN
Repligen CORPRepligen's CEO, Anthony Hunt, reports the acquisition of 2,504 shares and the disposal of 3,322 shares to cover tax obligations.
NASDAQ
RGEN
Repligen CORPChristine Gebski, SVP at Repligen Corp, reports acquisition of shares through a performance stock unit award and disposition of shares to cover tax obligations.
NASDAQ
RGEN
Repligen CORPChief Operating Officer James Bylund reports acquisition of 404 shares via performance stock units and disposal of 820 shares to cover tax obligations.
NASDAQ
RGEN
Repligen CORPJames Bylund, Chief Operating Officer of Repligen Corporation, was granted restricted stock units and stock options on February 27, 2024.
NASDAQ
RGEN
Repligen CORPRepligen's CEO, Anthony Hunt, was granted restricted stock units and stock options on February 27, 2024, as reported in a Form 4 filing with the SEC.
NASDAQ
RGEN
Repligen CORPForm 4: Repligen Corp Executive Ralf Kuriyel Reports Acquisition of Restricted Stock Units and Stock Options
Senior VP of R&D at Repligen Corp, Ralf Kuriyel, reports the acquisition of 3,520 restricted stock units and 3,497 stock options.
NASDAQ
RGEN
Repligen CORPRepligen's CFO, Jason K. Garland, reports the acquisition of restricted stock units and stock options, according to a Form 4 filing with the SEC.
NASDAQ
RGEN
Repligen CORPOlivier Loeillot, President and CCO of Repligen Corp, reports the acquisition of 2,880 shares of common stock and 2,860 stock options.
NASDAQ
RGEN
Repligen CORPDirector Karen A. Dawes exercised stock options and sold a portion of the acquired shares of Repligen Corp on February 27, 2024.